Cargando…
Towards the development of an epitope-focused vaccine for SARS-CoV-2
The rapid spread of COVID-19 on all continents and the mortality induced by SARS-CoV-2 virus, the cause of the pandemic coronavirus disease 2019 (COVID-19) has motivated an unprecedented effort for vaccine development. Inactivated viruses as well as vaccines focused on the partial or total sequence...
Ejemplares similares
-
An RBD-Based Diagnostic Method Useful for the Surveillance of Protective Immunity against SARS-CoV-2 in the Population
por: Ayón-Núñez, Dolores Adriana, et al.
Publicado: (2022) -
Characterization of S3Pvac Anti-Cysticercosis Vaccine Components: Implications for the Development of an Anti-Cestodiasis Vaccine
por: Rassy, Dunia, et al.
Publicado: (2010) -
Plasminogen-binding proteins as an evasion mechanism of the host’s innate immunity in infectious diseases
por: Ayón-Núñez, Dolores A., et al.
Publicado: (2018) -
Standardizing an Experimental Murine Model of Extraparenchymal Neurocysticercosis That Immunologically Resembles Human Infection
por: Espinosa-Cerón, Alejandro, et al.
Publicado: (2023) -
Pharmacokinetic Study of Intranasal Dexamethasone and Methylprednisolone Compared with Intravenous Administration: Two Open-Label, Single-Dose, Two-Period, Two-Sequence, Cross-Over Study in Healthy Volunteers
por: Cárdenas, Graciela, et al.
Publicado: (2022)